Pharmacy

At five years, no difference seen in symptoms, but rates of subsequent surgical treatment lower with methylprednisolone versus saline injection

Rate of high-risk COVID-19 outpatients needing prolonged emergency care or transfer to tertiary hospital lower with fluvoxamine versus placebo

Interim analysis shows lower risk for progression with sotrovimab versus placebo among high-risk patients with mild-to-moderate COVID-19

Incidence of events indicating loss of asthma control lower with itepekimab monotherapy in phase 2, proof-of-concept trial

At one and two years, 40 and 46 percent of patients initially receiving antibiotics underwent subsequent appendectomy

Scotland cohort study shows vaccination with ChAdOx1 nCoV-19, BNT162b2 highly effective for preventing deaths caused by delta variant

Global estimates decreased for coverage with third dose of DTP and polio vaccine, first dose of measles-containing vaccine

Among women with miscarriage, adjusted odds ratios for COVID-19 vaccination in previous three and five weeks were 0.91 and 0.81

Patients receiving attenuated adenovirus vaccine more likely to have no seroconversion, no detectable or diminished IgG response

Vaccine efficacy consistent in subgroups according to age, sex, race, and previous influenza vaccination